We consider BioShares Biotechnology not too risky. BioShares Biotechnology secures Sharpe Ratio (or Efficiency) of 0.1765 which signifies that BioShares Biotechnology had 0.1765% of return per unit of risk over the last 1 month. Our philosophy towards foreseeing volatility of a etf is to use all available market data together with company specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for BioShares Biotechnology Products which you can use to evaluate future volatility of the entity. Please confirm BioShares Biotechnology Downside Deviation of 1.32, Risk Adjusted Performance of 0.0792 and Mean Deviation of 0.8076 to double-check if risk estimate we provide are consistent with the epected return of 0.1947%.
|Time Horizon||30 Days Login to change|
BioShares Biotechnology Market Sensitivity
|One Month Beta |Analyze BioShares Biotechnology Demand TrendCheck current 30 days BioShares Biotechnology correlation with market (DOW)|
β = -1.0051
BioShares Biotechnology Technical Analysis
Projected Return Density Against MarketConsidering 30-days investment horizon, BioShares Biotechnology Products has beta of -1.0051 . This suggests Moreover, BioShares Biotechnology Products has an alpha of 0.4 implying that it can potentially generate 0.4% excess return over DOW after adjusting for the inherited market risk (beta).
Considering 30-days investment horizon, the coefficient of variation of BioShares Biotechnology is 566.67. The daily returns are destributed with a variance of 1.22 and standard deviation of 1.1. The mean deviation of BioShares Biotechnology Products is currently at 0.87. For similar time horizon, the selected benchmark (DOW) has volatility of 0.45